The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

New drugs and where they fit in the treatment algorithm

Publication date: Wednesday, 06 October 2010
Contributor(s): Mike Kirby

In May 2009, NICE published recommendations on the use of newer agents for the control of blood glucose in type 2 diabetes. This guideline provides a partial update for NICE Clinical Guideline 66 on the management of type 2 diabetes that was published last year. These newer agents include the dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), the glucagon-like peptide-1 (GLP-1) mimetic exenatide and the long-acting insulin analogues (insulin detemir and insulin glargine).

Category: Editorial
Edition: Volume 2 Number 2 Jul-Aug-Sep 2009
Contributor(s): Mike Kirby

Article search and filter